Abstract Smoking prevalence in Switzerland is on the decline, albeit slowly, despite anti-smoking campaigns aimed at raising awareness of the health risks involved in smoking. After years of efforts against smoking and smoking bans, the smoking population in Switzerland was reduced but, at the same time, the number of smokers who wanted to quit using an NRT method has also reduced. Overall, 1.7 million Swiss consumers smoke, which accounts for 24% of the population in the country. Many smokers are not in...
Euromonitor International's NRT Smoking Cessation Aids in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the NRT Smoking Cessation Aids market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Content NRT Smoking Cessation Aids in Switzerland
List Of Contents And Tables
NRT SMOKING CESSATION AIDS IN SWITZERLAND KEY DATA FINDINGS 2022 DEVELOPMENTS Modest positive performance seen, as the high number of smokers in Switzerland slowly declines Janssen-Cilag’s Nicorette brand maintains its top place with the lion’s share of sales Competition from “reduced-risk products” suppresses stronger growth PROSPECTS AND OPPORTUNITIES Slow growth expected, in line with gradually reducing number of smokers in the country Innovation expected in flavours and packaging, to compete with the rising trends for vaping and heated tobacco Holistic smoking cessation trends arise, from hypnotherapy to laser therapy CATEGORY INDICATORS Table 1 Number of Smokers by Gender 2017-2022 CATEGORY DATA Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2017-2022 Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2017-2022 Table 4 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2018-2022 Table 5 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2019-2022 Table 6 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2022-2027 Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2022-2027 CONSUMER HEALTH IN SWITZERLAND EXECUTIVE SUMMARY Consumer health in 2022: The big picture 2022 key trends Competitive landscape Retailing developments What next for consumer health? MARKET INDICATORS Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022 Table 9 Life Expectancy at Birth 2017-2022 MARKET DATA Table 10 Sales of Consumer Health by Category: Value 2017-2022 Table 11 Sales of Consumer Health by Category: % Value Growth 2017-2022 Table 12 NBO Company Shares of Consumer Health: % Value 2018-2022 Table 13 LBN Brand Shares of Consumer Health: % Value 2019-2022 Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022 Table 15 Distribution of Consumer Health by Format: % Value 2017-2022 Table 16 Distribution of Consumer Health by Format and Category: % Value 2022 Table 17 Forecast Sales of Consumer Health by Category: Value 2022-2027 Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027 APPENDIX OTC registration and classification Vitamins and dietary supplements registration and classification Self-medication/self-care and preventive medicine Switches Summary 1 OTC: Reverse Switches 2021-2022 DISCLAIMER DEFINITIONS SOURCES Summary 2 Research Sources
Smoking prevalence in Switzerland is on the decline, albeit slowly, despite anti-smoking campaigns aimed at raising awareness of the health risks involved in smoking. After years of efforts against smoking and smoking bans, the smoking population in Switzerland was reduced but, at the same time, the number of smokers who wanted to quit using an NRT method has also reduced. Overall, 1.7 million Swiss consumers smoke, which accounts for 24% of the population in the country. Many smokers are not in...
Euromonitor International's NRT Smoking Cessation Aids in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the NRT Smoking Cessation Aids market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
NRT Smoking Cessation Aids in Switzerland
List Of Contents And Tables
NRT SMOKING CESSATION AIDS IN SWITZERLAND KEY DATA FINDINGS 2022 DEVELOPMENTS Modest positive performance seen, as the high number of smokers in Switzerland slowly declines Janssen-Cilag’s Nicorette brand maintains its top place with the lion’s share of sales Competition from “reduced-risk products” suppresses stronger growth PROSPECTS AND OPPORTUNITIES Slow growth expected, in line with gradually reducing number of smokers in the country Innovation expected in flavours and packaging, to compete with the rising trends for vaping and heated tobacco Holistic smoking cessation trends arise, from hypnotherapy to laser therapy CATEGORY INDICATORS Table 1 Number of Smokers by Gender 2017-2022 CATEGORY DATA Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2017-2022 Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2017-2022 Table 4 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2018-2022 Table 5 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2019-2022 Table 6 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2022-2027 Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2022-2027 CONSUMER HEALTH IN SWITZERLAND EXECUTIVE SUMMARY Consumer health in 2022: The big picture 2022 key trends Competitive landscape Retailing developments What next for consumer health? MARKET INDICATORS Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022 Table 9 Life Expectancy at Birth 2017-2022 MARKET DATA Table 10 Sales of Consumer Health by Category: Value 2017-2022 Table 11 Sales of Consumer Health by Category: % Value Growth 2017-2022 Table 12 NBO Company Shares of Consumer Health: % Value 2018-2022 Table 13 LBN Brand Shares of Consumer Health: % Value 2019-2022 Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022 Table 15 Distribution of Consumer Health by Format: % Value 2017-2022 Table 16 Distribution of Consumer Health by Format and Category: % Value 2022 Table 17 Forecast Sales of Consumer Health by Category: Value 2022-2027 Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027 APPENDIX OTC registration and classification Vitamins and dietary supplements registration and classification Self-medication/self-care and preventive medicine Switches Summary 1 OTC: Reverse Switches 2021-2022 DISCLAIMER DEFINITIONS SOURCES Summary 2 Research Sources